Pasithea Therapeutics Corp. (NASDAQ:KTTA) Stock Gains After Private Placement
The clinical stage biotech firm Pasithea Therapeutics Corp. (NASDAQ:KTTA) had been in considerable focus yesterday, and that became apparent in
Read moreThe clinical stage biotech firm Pasithea Therapeutics Corp. (NASDAQ:KTTA) had been in considerable focus yesterday, and that became apparent in
Read moreThere have been a fair number of stocks that have clocked notable gains over the past few days and many
Read morePasithea Therapeutics (NASDAQ:KTTA) was up 155% on Tuesday after the company added esketamine nasal spray to its offerings in the
Read more